These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25851937)
1. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States. Nabhan C; Byrtek M; Rai A; Dawson K; Zhou X; Link BK; Friedberg JW; Zelenetz AD; Maurer MJ; Cerhan JR; Flowers CR Br J Haematol; 2015 Jul; 170(1):85-95. PubMed ID: 25851937 [TBL] [Abstract][Full Text] [Related]
2. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study. Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156 [TBL] [Abstract][Full Text] [Related]
3. Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. Nabhan C; Byrtek M; Taylor MD; Friedberg JW; Cerhan JR; Hainsworth JD; Miller TP; Hirata J; Link BK; Flowers CR Cancer; 2012 Oct; 118(19):4842-50. PubMed ID: 22434428 [TBL] [Abstract][Full Text] [Related]
4. What is the optimal management of early-stage low-grade follicular lymphoma in the modern era? Vargo JA; Gill BS; Balasubramani GK; Beriwal S Cancer; 2015 Sep; 121(18):3325-34. PubMed ID: 26042364 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Wagner-Johnston ND; Link BK; Byrtek M; Dawson KL; Hainsworth J; Flowers CR; Friedberg JW; Bartlett NL Blood; 2015 Aug; 126(7):851-7. PubMed ID: 26105149 [TBL] [Abstract][Full Text] [Related]
6. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy. Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639 [TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project. Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646 [TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years. Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group. Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A; Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996 [TBL] [Abstract][Full Text] [Related]
12. Maintenance rituximab in Veterans with follicular lymphoma. Halwani AS; Rasmussen KM; Patil V; Morreall D; Li C; Yong C; Burningham Z; Dawson K; Masaquel A; Henderson K; DeLong-Sieg E; Sauer BC Cancer Med; 2020 Oct; 9(20):7537-7547. PubMed ID: 32860335 [TBL] [Abstract][Full Text] [Related]
13. Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. Casulo C; Friedberg JW; Ahn KW; Flowers C; DiGilio A; Smith SM; Ahmed S; Inwards D; Aljurf M; Chen AI; Choe H; Cohen J; Copelan E; Farooq U; Fenske TS; Freytes C; Gaballa S; Ganguly S; Jethava Y; Kamble RT; Kenkre VP; Lazarus H; Lazaryan A; Olsson RF; Rezvani AR; Rizzieri D; Seo S; Shah GL; Shah N; Solh M; Sureda A; William B; Cumpston A; Zelenetz AD; Link BK; Hamadani M Biol Blood Marrow Transplant; 2018 Jun; 24(6):1163-1171. PubMed ID: 29242111 [TBL] [Abstract][Full Text] [Related]
14. Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-up. Nicolas-Virelizier E; Ségura-Ferlay C; Ghesquières H; Chassagne-Clément C; Gargi T; Biron P; Belhabri A; Rey P; Faurie P; Chabaud S; Sebban C Hematol Oncol; 2015 Mar; 33(1):1-8. PubMed ID: 24496668 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults. Gangatharan SA; Maganti M; Kuruvilla JG; Kukreti V; Tiedemann RE; Gospodarowicz MK; Hodgson DC; Sun A; Tsang RW; Pintilie M; Crump M Br J Haematol; 2015 Aug; 170(3):384-90. PubMed ID: 25904266 [TBL] [Abstract][Full Text] [Related]
16. Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States. Nabhan C; Zhou X; Day BM; Dawson K; Zelenetz AD; Friedberg JW; Cerhan JR; Link BK; Flowers CR Am J Hematol; 2016 Aug; 91(8):770-5. PubMed ID: 27124800 [TBL] [Abstract][Full Text] [Related]
17. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group. Méndez M; Torrente M; Sánchez-Beato M; González-Rincón J; Royuela A; Gómez-Codina J; de la Cruz-Merino L; Rueda A; Llanos M; Quero C; Rodríguez-Abreu D; Gumá J; Monsalvo S; Sabin P; Provencio M Hematol Oncol; 2019 Apr; 37(2):143-150. PubMed ID: 30840776 [TBL] [Abstract][Full Text] [Related]
18. The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras. Nabhan C; Aschebrook-Kilfoy B; Chiu BC; Kruczek K; Smith SM; Evens AM Am J Hematol; 2014 Jun; 89(6):633-8. PubMed ID: 24633911 [TBL] [Abstract][Full Text] [Related]
19. Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts. Sarkozy C; Maurer MJ; Link BK; Ghesquieres H; Nicolas E; Thompson CA; Traverse-Glehen A; Feldman AL; Allmer C; Slager SL; Ansell SM; Habermann TM; Bachy E; Cerhan JR; Salles G J Clin Oncol; 2019 Jan; 37(2):144-152. PubMed ID: 30481079 [TBL] [Abstract][Full Text] [Related]